News Conference News TCT 2018 Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos Michael O'Riordan October 02, 2018
News Conference News TCT 2018 PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience L.A. McKeown September 27, 2018
News Conference News TCT 2018 More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses Michael O'Riordan September 24, 2018
News Conference News TCT 2018 OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients Todd Neale September 24, 2018
News Conference News TCT 2018 EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis Michael O'Riordan September 21, 2018
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018
News Daily News Aspirin Falters Yet Again in Primary Prevention: ASPREE Michael O'Riordan September 17, 2018
News Conference News ESC 2018 My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More Shelley Wood September 14, 2018
News Daily News Benefits of Dairy, Particularly Milk and Yogurt, Get Boost in New PURE Analysis Michael O'Riordan September 13, 2018
News Daily News Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows Michael O'Riordan September 12, 2018
News Daily News Newly Defined Stage 1 Hypertension Tied to CVD Risk in Younger Chinese Adults Todd Neale September 07, 2018
News Conference News ESC 2018 ASCOT Legacy: Calcium Channel Blockers, Statins Confer Long-term Survival Benefits in Hypertensive Patients L.A. McKeown August 31, 2018
News Conference News ESC 2018 Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE Michael O'Riordan August 28, 2018
News Conference News ESC 2018 Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND Michael O'Riordan August 26, 2018
News Conference News ESC 2018 ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients Todd Neale August 26, 2018
News Conference News ESC 2018 MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis Todd Neale August 26, 2018
News Conference News ESC 2018 Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE Shelley Wood August 26, 2018
News Conference News ESC 2018 Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61 Michael O'Riordan August 26, 2018
News Daily News Reducing CV Risk May Improve Brain Health at Any Stage in Life, Studies Hint Todd Neale August 22, 2018